Comparison between Beacon Trusteeship IPO and Quest Laboratories IPO.
Beacon Trusteeship IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Quest Laboratories IPO is a SME Bookbuilding proposed to list at NSE SME.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Shreni Shares Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beacon Trusteeship IPO is up to ₹30.89 Cr whereas the issue size of the Quest Laboratories IPO is up to ₹40.95 Cr. The final issue price of Beacon Trusteeship IPO is ₹60.00 per share and of Quest Laboratories IPO is ₹97.00 per share.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹57.00 per share | ₹93.00 per share |
| Issue Price (Upper) | ₹60.00 per share | ₹97.00 per share |
| Issue Price (Final) | ₹60.00 per share | ₹97.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 36,00,000 shares | 42,21,600 shares |
| Fresh Issue Size (Amount) | up to ₹21.60 Cr | up to ₹40.95 Cr |
| OFS Issue Size | 15,48,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹9.29 Cr | up to ₹0.00 Cr |
| Issue Size Total | 51,48,000 shares | 42,21,600 shares |
| Issue Size Total (Amount) | up to ₹30.89 Cr | up to ₹40.95 Cr |
Beacon Trusteeship IPO opens on May 28, 2024, while Quest Laboratories IPO opens on May 15, 2024. The closing date of Beacon Trusteeship IPO and Quest Laboratories IPO is May 30, 2024, and May 17, 2024, respectively.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |
|---|---|---|
| Anchor Bid Date | May 27, 2024 | May 14, 2024 |
| Issue Open | May 28, 2024 | May 15, 2024 |
| Issue Close | May 30, 2024 | May 17, 2024 |
| Basis Of Allotment (Tentative) | May 31, 2024 | May 21, 2024 |
| Initiation of Refunds (Tentative) | Jun 03, 2024 | May 22, 2024 |
| Credit of Share (Tentative) | Jun 03, 2024 | May 22, 2024 |
| Listing date (Tentative) | Jun 04, 2024 | May 23, 2024 |
| Anchor Lockin End date 1 | Jun 30, 2024 | Jun 20, 2024 |
| Anchor Lockin End date 2 | Aug 29, 2024 | Aug 19, 2024 |
Beacon Trusteeship IPO P/E ratio is 16.49, as compared to Quest Laboratories IPO P/E ratio of 23.03.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Beacon Trusteeship Limited Financial Information (Restated Consolidated)Beacon Trusteeship Limited's revenue increased by 33% and profit after tax (PAT) rose by 34.25% between the financial year ending with March 31, 2024 and March 31, 2023.
| Quest Laboratories Limited Financial Information (Restated)Quest Laboratories Limited's revenue increased by 3.9% and profit after tax (PAT) rose by 22.5% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 67.88 | 90.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 46.14 | 65.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 16.49 | 23.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹108.39 Cr. | ₹158.96 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 31.12% | 34.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 41.86% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.64 | ₹4.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.95% | 34.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Beacon Trusteeship IPO Retail Individual Investors (RII) are offered 18,02,000 shares while in Quest Laboratories IPO retail investors are offered 18,02,000 shares. Qualified Institutional Buyers (QIB) are offered 10,30,000 shares in Beacon Trusteeship IPO and 8,31,600 shares in Quest Laboratories IPO.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |
|---|---|---|
| Anchor Investor Reserveration | 15,42,000 shares | 12,36,000 shares |
| Market Maker Reserveration | 2,72,000 shares | 2,28,000 shares |
| QIB | 10,30,000 shares | 8,31,600 shares |
| NII | 7,74,000 shares | 6,55,200 shares |
| RII | 18,02,000 shares | 14,98,800 shares |
| Employee | ||
| Others | ||
| Total | 51,48,000 shares | 42,21,600 shares |
Beacon Trusteeship IPO subscribed 465.20x in total, whereas Quest Laboratories IPO subscribed 85.26x.
| Beacon Trusteeship IPO | Quest Laboratories IPO | |
|---|---|---|
| QIB (times) | 163.86x | 57.20x |
| NII (times) | 779.38x | 184.10x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 502.49x | 57.63x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 465.20x | 85.26x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
